This alternative combined data from 10 disparate resource systems to provide Affinity’s business users with a one-stop shop for claim, provider, membership/high quality, pharmacy and behavioral wellness information. Future releases will centralize the foundation of accurate information, reduce human error, allow cost saving and can ultimately improve decision making. The program is likely to accomplish an ROI of 31 % within the first year of creation. As we embarked upon this initiative, one of the many unknowns was what level of data issues we would encounter. Not uncommon with other mid-size agencies, Affinity had an extremely small pool of subject matter experts that had accurate in-depth knowledge of the foundation systems and the info included within those systems that feed the enterprise data warehouse.TCT 2010 will need place September 21 – 25 in Washington, DC. Data from these trials are anticipated to impact the practice of interventional cardiovascular medication and have an immediate impact on guidelines and individual care. These presented trials will become highlighted during sessions throughout TCT. TUESDAY, 21 SEPTEMBER, 6:00 PM – 7:45 PM SYNTAX Still left Main: Three-Season Outcomes from a Potential Randomized Trial of Paclitaxel-Eluting Stents In comparison to Bypass Graft Surgery in Patients with Left Main Coronary Artery Disease SYNTAX 3VD: Three-Year Outcomes from a Potential Randomized Trial of Paclitaxel-Eluting Stents In comparison to Bypass Graft Surgery in Patients with Triple Vessel Coronary Artery Disease EXECUTIVE: A Prospective Randomized Trial of Everolimus-Eluting Stents In comparison to Paclitaxel-Eluting Stents in Sufferers with Multivessel Coronary Artery Disease DECLARE-LONG II: A Prospective Randomized Trial of Triple vs.